Bicycle Therapeutics Plc (BCYC)
4.88
-0.27
(-5.24%)
USD |
NASDAQ |
May 07, 15:25
Bicycle Therapeutics Shareholders Equity (Quarterly) : 554.32M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | 40.92M |
| NuCana Plc | 32.72M |
| DBV Technologies SA | 168.77M |
| Cellectis SA | 75.90M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 652.40M |
| Total Liabilities (Quarterly) | 98.08M |
| Debt to Equity Ratio | 0.0288 |
| Current Ratio | 12.66 |
| Net Debt Paydown Yield | -0.40% |